newsfilter
← Latest News
GlobeNewswire·

Heron Therapeutics Announces Third Quarter 2026 Financial Results

Q3 2026 net revenue of $35.3 million; ZYNRELEF® net revenue up 13.8% and APONVIE® net revenue up 49.3% compared to the third quarter of 2025Entered into a definitive agreement under which CorMedix Therapeutics will